Aging in the 21st Century

In recent years, the prevalence of Alzheimer’s disease has climbed to the number six spot as a leading cause of death. Currently, it affects 5.7 million people and their caregivers. These skyrocketing statistics have made the development of efficacious, novel treatments a global health priority. To address this urgent need for intervention and treatment of Alzheimer’s disease and related disorders, the UM Department of Psychiatry and Behavioral Sciences established the Center for Cognitive Neuroscience and Aging (CNSA) in June of 2018. Led by Dr. David Loewenstein, the Center is staffed by a highly regarded team of clinical investigators to provide innovative clinical trials as well as novel cognitive, behavioral and psychosocial interventions for patients and their families.